비씨월드제약: directors' dealings · South Korea · DART (FSS) DART:company-57c575 KR KR · DART (FSS) Mcap 56.3Bn€
Explore the full directors' dealings record of 비씨월드제약, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Market capitalisation: €56.3bn. The latest transaction was reported on 14 April 2026 — Purchase. Among the most active insiders: 홍성한. Every trade is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 75.80 Bn€
Gross profit 30.59 Bn€ 40% margin
Net income −4.90 Bn€ -6.5% margin
Balance sheet & cash
Market cap 56.33 Bn€
Total debt 87.16 Bn€
Free Cash Flow 1.57 Bn€
Last declaration on 14 April 2026
Declarations 5 total
Executives ● Purchase2 DART
€837,671 318,574 shares
DART:20260414001749 · 14 Apr 2026
Ideal exit: 9 Jan 2027 (T+270) Executives ● Purchase30 DART
€22,607 196,237 shares @ €0.1152 0.0000% mcap 100.0% of flow
DART:20260401002538 · 26 Mar 2026
Ideal exit: 21 Dec 2026 (T+270) Executives ● Purchase30 DART
€14,022 121,722 shares @ €0.1152 0.0000% mcap 100.0% of flow
DART:20260401002395 · 26 Mar 2026
Ideal exit: 21 Dec 2026 (T+270) Executives ● Purchase10 DART
€632 65,883 shares @ €0.1152 0.0000% mcap 100.0% of flow
DART:20260401002343 · 26 Mar 2026
Ideal exit: 21 Dec 2026 (T+270) Executives ● Purchase30 DART
€173 1,505 shares @ €0.1152 0.0000% mcap 100.0% of flow
DART:20260401002295 · 26 Mar 2026
Ideal exit: 21 Dec 2026 (T+270)